Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Brooks Laboratories Ltd

NSE: BROOKS · BSE: 533543 · Pharmaceuticals & Biotechnology · 19 announcements

Share price
₹58.51
Market cap
₹172.3 Cr
Revenue (annual)
₹85.74 Cr
Net profit (annual)
₹24.58 Cr
P/E (TTM)
13.1×Sector 47.4×
Promoter holding
52.62%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:45 IST BSE
Management Change

Brooks Laboratories Management Change

Brooks Laboratories Ltd announced the resignation of Ms. Krutika Rane, Company Secretary and Compliance Officer, effective October 9, 2026.

15:52 IST BSE
Annual General Meeting

Brooks Laboratories Annual General Meeting

Brooks Laboratories Limited conducted its 24th Annual General Meeting on September 3, 2026. Shareholders transacted ordinary business, including the adoption of financial statements and director appointments.

16:51 IST BSE
Annual General Meeting

Brooks Laboratories Annual General Meeting

Brooks Laboratories issued an addendum to its 24th Annual General Meeting notice. The amendment modifies Resolution No. 4 regarding corporate guarantee arrangements.

18:14 IST BSE
Other Announcement

Brooks Laboratories Other Announcement

Brooks Laboratories is informing shareholders about the availability of the Annual Report for FY 2025-26 and requesting KYC updates in compliance with regulatory requirements.

18:05 IST BSE
Annual General Meeting

Brooks Laboratories Annual General Meeting

Brooks Laboratories Ltd has issued the notice for its 24th Annual General Meeting scheduled for September 3, 2026, along with the Annual Report for 2025-26.